UNSPSC 51383703: Lobuprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C25H33ClN2O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X2T6O1TUNX, chemically known as propanoic acid, 2-(4-(2-methylpropyl)phenyl)-, 2-(4-(3-chlorophenyl)-1-piperazinyl)ethyl ester, hydrochloride but generally known as lobuprofen, which bears US NIH Compound Identifier 65842. European Medicines Agency schedules Lobuprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08545MIG.

UNSPSC 51383703 Ibuprofen, a Commodity code, encompasses pharmaceutical products that state and local governments procure through competitive bidding and cooperative purchasing arrangements, though recent solicitations tagged to this code show limited direct activity for ibuprofen itself. The actual work being solicited under related pharmaceutical commodity codes reflects state and local demand for generic multi-source medications, over-the-counter products, naloxone, and prescription fulfillment systems sourced through authorized wholesalers and direct-to-manufacturer channels. Issuing bodies include state health and human services departments, county community health programs, and multistate cooperative purchasing alliances. Vendors in this space must maintain FDA compliance, cGMP certification, Drug Supply Chain Security Act (DSCSA) adherence, and substantial commercial general liability insurance ($2 million to $5 million per occurrence). Contracts typically run two years with renewal options and impose administrative fees (often 3 percent) alongside fixed or net-price pricing structures negotiated through authorized wholesaler networks.

Recent activity spans multiple states and procurement models. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026, due March 26, 2026, seeking generic multi-source pharmaceuticals and OTC products for distribution across participating state and local facilities including Oregon, with awarded vendors effective July 1, 2026. Seminole County, Florida posted IFB60459723LAS on June 30, 2026, due July 26, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The Texas Health and Human Services Commission issued RFI HHS0017013 in early April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling state-level interest in alternative pharmacy supply models outside traditional PBM and wholesaler arrangements. Cooperative purchasing vehicles and direct-sourcing pilots suggest an expanding procurement landscape, though the ibuprofen commodity code itself shows limited recent direct solicitation activity.